Regen BioPharma Inc Pref Share RGBPP
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover RGBPP, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.
News
-
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024
Trading Information
- Previous Close Price
- $3.20
- Day Range
- $3.20–3.20
- 52-Week Range
- $1.50–12.00
- Bid/Ask
- $1.95 / $3.20
- Market Cap
- $1.31 Mil
- Volume/Avg
- 157 / 477
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
Valuation
|
Metric
|
RGBPP
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGBPP
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
Interest Coverage | −11.91 |
Quick Ratio
RGBPP
Profitability
|
Metric
|
RGBPP
|
|---|---|
Return on Assets (Normalized) | −273.49% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RGBPP
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ggkmltckp | Yrqy | $550.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Bsfztjb | Yyhlj | $101.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gkzhmvkc | Kflvxl | $98.1 Bil | |
MRNA
| Moderna Inc | Wdxbbwcsq | Zmpp | $39.1 Bil | |
ARGX
| argenx SE ADR | Gvjftjyq | Ywpp | $21.7 Bil | |
BNTX
| BioNTech SE ADR | Yqhbspb | Xvdx | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Csxpgjfj | Skkrldn | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Knzthrqmg | Shmzl | $17.1 Bil | |
RPRX
| Royalty Pharma PLC Class A | Myznfncnk | Vqvdc | $12.5 Bil | |
INCY
| Incyte Corp | Spkkjwxzr | Ptfdfy | $11.9 Bil |